Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innovex International (INVX) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Innovex International (INVX) over the last 17 years, with Q3 2025 value amounting to $163.4 million.

  • Innovex International's Cash & Equivalents rose 6354.57% to $163.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $163.4 million, marking a year-over-year increase of 6354.57%. This contributed to the annual value of $73.3 million for FY2024, which is 88944.1% up from last year.
  • Latest data reveals that Innovex International reported Cash & Equivalents of $163.4 million as of Q3 2025, which was up 6354.57% from $68.8 million recorded in Q2 2025.
  • Over the past 5 years, Innovex International's Cash & Equivalents peaked at $375.2 million during Q3 2021, and registered a low of $7.4 million during Q4 2023.
  • For the 5-year period, Innovex International's Cash & Equivalents averaged around $160.7 million, with its median value being $99.9 million (2024).
  • In the last 5 years, Innovex International's Cash & Equivalents crashed by 9718.58% in 2021 and then soared by 110254.0% in 2024.
  • Quarter analysis of 5 years shows Innovex International's Cash & Equivalents stood at $9.7 million in 2021, then fell by 13.56% to $8.4 million in 2022, then dropped by 12.0% to $7.4 million in 2023, then skyrocketed by 889.44% to $73.3 million in 2024, then surged by 122.95% to $163.4 million in 2025.
  • Its Cash & Equivalents stands at $163.4 million for Q3 2025, versus $68.8 million for Q2 2025 and $68.1 million for Q1 2025.